Lynch Regenerative Medicine has completed participant enrolment in a Phase II trial assessing the rhPDGF-BB as an adjunctive therapy for...
BeOne Medicines, the BeOne Care Foundation, and The Max Foundation have extended their Brukinsa access programme for CLL until 2028.The...
Johnson & Johnson (J&J) has received the US Food and Drug Administration (FDA) 510(k) clearance for the MONARCH QUEST 3...
Leal Therapeutics has completed a $30m extension of its Series A financing to support advancement of its investigational therapies for...
Fulcrum Therapeutics and Slate Medicines have signed a definitive agreement to merge in an all-stock transaction backed by a $245m...
Nanochon has secured the Panamá’s Ministry of Health approval to begin its first-in-human trial of the Chondrograft implant.The post Nanochon...
ArkBio has received approval from the FDA to begin a Phase II clinical trial of its AK0529 for use in...
Phanes Therapeutics has received fast track designation from the US FDA for spevatamig to treat patients with advanced and metastatic...
Optellum and Coreline Soft have announced plans to integrate AI to support lung nodule detection and management across international markets...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.